Integrated Investment Consultants’s Impax Laboratories, Inc. IPXL Stock Holding History

Integrated Investment Consultants’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-100	Closed	-$2K	–	824
2018 Q1	$2K	Buy	+100	New	+$1.96K	﹤0.01%	816
2017 Q3	$2K	Hold	100	–	–	﹤0.01%	614
2017 Q2	$2K	Hold	100	–	–	﹤0.01%	571
2017 Q1	$1K	Hold	100	–	–	﹤0.01%	578
2016 Q4	$1K	Hold	100	–	–	﹤0.01%	576
2016 Q3	$2K	Hold	100	–	–	﹤0.01%	580
2016 Q2	$3K	Hold	100	–	–	﹤0.01%	577
2016 Q1	$3K	Buy	+100	New	+$3.52K	﹤0.01%	574

Integrated Investment Consultants's IPXL Position: Q2 2018 in Review

Integrated Investment Consultants sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 100 shares — an estimated $2K sold.

Integrated Investment Consultants first reported a position in IPXL in Q1 2016 and held it in 8 quarters. The position peaked at $3K in Q2 2016. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.

Integrated Investment Consultants reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
Integrated Investment Consultants sold 100 Impax Laboratories, Inc. shares in Q2 2018, an estimated $2K.
Integrated Investment Consultants first reported a position in Impax Laboratories, Inc. in Q1 2016 and held it in 8 quarters.
Integrated Investment Consultants's Impax Laboratories, Inc. position peaked at $3K in Q2 2016.
1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.

Based on Integrated Investment Consultants's 13F filing for Q2 2018, filed 1 Aug 2018.